Document
Allergan, Inc. v. Teva Pharmaceuticals USA, Inc. et al, 2:15-cv-01455, No. 536-2 (E.D.Tex. Nov. 6, 2017)
Cite Document
Allergan, Inc. v. Teva Pharmaceuticals USA, Inc. et al, 2:15-cv-01455, No. 536-2 (E.D.Tex. Nov. 6, 2017)
+ More Snippets
Document
Allergan, Inc. v. Teva Pharmaceuticals USA, Inc. et al, 2:15-cv-01455, No. 536-4 (E.D.Tex. Nov. 6, 2017)
Cite Document
Allergan, Inc. v. Teva Pharmaceuticals USA, Inc. et al, 2:15-cv-01455, No. 536-4 (E.D.Tex. Nov. 6, 2017)
+ More Snippets
Document
Allergan, Inc. v. Teva Pharmaceuticals USA, Inc. et al, 2:15-cv-01455, No. 536-3 (E.D.Tex. Nov. 6, 2017)
Cite Document
Allergan, Inc. v. Teva Pharmaceuticals USA, Inc. et al, 2:15-cv-01455, No. 536-3 (E.D.Tex. Nov. 6, 2017)
+ More Snippets
Document
Allergan, Inc. v. Teva Pharmaceuticals USA, Inc. et al, 2:15-cv-01455, No. 536-1 (E.D.Tex. Nov. 6, 2017)
Cite Document
Allergan, Inc. v. Teva Pharmaceuticals USA, Inc. et al, 2:15-cv-01455, No. 536-1 (E.D.Tex. Nov. 6, 2017)
+ More Snippets
Document
IPR2017-00568, No. 5 Motion - 162 Joinder Motion (P.T.A.B. Jan. 6, 2017)
Cite Document
IPR2017-00568, No. 5 Motion - 162 Joinder Motion (P.T.A.B. Jan. 6, 2017)
+ More Snippets
Document
IPR2017-00568, No. 4 Petition - 162 Petition (P.T.A.B. Jan. 6, 2017)
Cite Document
IPR2017-00568, No. 4 Petition - 162 Petition (P.T.A.B. Jan. 6, 2017)
+ More Snippets
Document
IPR2017-00599, No. 2 Petition - Petition for IPR of Patent No 8,533,162 (P.T.A.B. Jan. 6, 2017)
Cite Document
IPR2017-00599, No. 2 Petition - Petition for IPR of Patent No 8,533,162 (P.T.A.B. Jan. 6, 2017)
+ More Snippets
Document
IPR2017-00599, No. 3 Motion - Motion to Joinder (P.T.A.B. Jan. 6, 2017)
Cite Document
IPR2017-00599, No. 3 Motion - Motion to Joinder (P.T.A.B. Jan. 6, 2017)
+ More Snippets
Document
Allergan, Inc. v. Teva Pharmaceuticals USA, Inc. et al, 2:15-cv-01455, No. 529-1 (E.D.Tex. Oct. 30, 2017)
Cite Document
Allergan, Inc. v. Teva Pharmaceuticals USA, Inc. et al, 2:15-cv-01455, No. 529-1 (E.D.Tex. Oct. 30, 2017)
+ More Snippets
Document
Allergan, Inc. v. Teva Pharmaceuticals USA, Inc. et al, 2:15-cv-01455, No. 531-1 (E.D.Tex. Oct. 30, 2017)
Cite Document
Allergan, Inc. v. Teva Pharmaceuticals USA, Inc. et al, 2:15-cv-01455, No. 531-1 (E.D.Tex. Oct. 30, 2017)
+ More Snippets
Document
Allergan, Inc. v. Teva Pharmaceuticals USA, Inc. et al, 2:15-cv-01455, No. 530-1 (E.D.Tex. Oct. 30, 2017)
Cite Document
Allergan, Inc. v. Teva Pharmaceuticals USA, Inc. et al, 2:15-cv-01455, No. 530-1 (E.D.Tex. Oct. 30, 2017)
+ More Snippets
Document
IPR2016-01130, No. 58 Reply - Petitioners Reply in Support of Petitioners Motion to Exclude Evidence (P.T.A.B. Aug. 3, 2017)
Cite Document
IPR2016-01130, No. 58 Reply - Petitioners Reply in Support of Petitioners Motion to Exclude Evidence (P.T.A.B. Aug. 3, 2017)
+ More Snippets
Document
IPR2017-00568, No. 19 Exhibit List - 162 Patent Petitioners Updated Exhibit List (P.T.A.B. Aug. 29, 2017)
Cite Document
IPR2017-00568, No. 19 Exhibit List - 162 Patent Petitioners Updated Exhibit List (P.T.A.B. Aug. 29, 2017)
+ More Snippets
Document
IPR2016-01130, No. 52 Opposition - Petitioners Opposition to Patent Owners Motion to Exclude Evidence (P.T.A.B. Jul. 27, 2017)
Cite Document
IPR2016-01130, No. 52 Opposition - Petitioners Opposition to Patent Owners Motion to Exclude Evidence (P.T.A.B. Jul. 27, 2017)
+ More Snippets
Document
Allergan, Inc. v. Teva Pharmaceuticals USA, Inc. et al, 2:15-cv-01455, No. 517-2 (E.D.Tex. Oct. 13, 2017)
Cite Document
Allergan, Inc. v. Teva Pharmaceuticals USA, Inc. et al, 2:15-cv-01455, No. 517-2 (E.D.Tex. Oct. 13, 2017)
+ More Snippets